Intermittent fasting activates macrophage migration inhibitory factor and alleviates high-fat diet-induced nonalcoholic fatty liver disease

Switching to normal diet (ND) is the regular therapy for high-fat diet (HFD)-induced nonalcoholic fatty liver disease (NAFLD). Intermittent fasting (IF) is a unique treatment which may exhibits better therapeutic efficacy. Thus, we aim to investigate the therapeutic effects of these treatments and e...

Full description

Saved in:
Bibliographic Details
Published inScientific reports Vol. 13; no. 1; pp. 13068 - 9
Main Authors Li, Dezhao, Dun, Yaoshan, Qi, Dake, Ripley-Gonzalez, Jeffrey W., Dong, Jie, Zhou, Nanjiang, Qiu, Ling, Zhang, Jie, Zeng, Tanghao, You, Baiyang, Liu, Suixin
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 11.08.2023
Nature Publishing Group
Nature Portfolio
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Switching to normal diet (ND) is the regular therapy for high-fat diet (HFD)-induced nonalcoholic fatty liver disease (NAFLD). Intermittent fasting (IF) is a unique treatment which may exhibits better therapeutic efficacy. Thus, we aim to investigate the therapeutic effects of these treatments and exploring the mechanisms. In the present study, NAFLD mouse model was induced by a 10-week HFD. Thereafter, mice adopted continued HFD, ND, or IF for the next 12 weeks. Finally, the liver was then harvested to assess lipid deposition, lipid metabolism, apoptosis, and autophagy, while blood was collected to determine blood glucose and insulin. The results showed that IF and ND treatment improved lipid deposition and metabolic disorder of NAFLD mice; the increasing body weight, liver weight, and HOMA-IR index of HFD mice were also alleviated by IF and ND. Furthermore, IF and ND treatment activated the macrophage migration inhibitory factor (MIF)/AMPK pathway and regulated its downstream autophagy and apoptosis. However, the efficacy of IF was better than ND. Both IF and ND activates MIF signaling and alleviate the lipotoxicity of NAFLD while IF therapy is more effective than ND. The different MIF up-regulation might be the underlying mechanism of why IF benefits more than ND.
AbstractList Switching to normal diet (ND) is the regular therapy for high-fat diet (HFD)-induced nonalcoholic fatty liver disease (NAFLD). Intermittent fasting (IF) is a unique treatment which may exhibits better therapeutic efficacy. Thus, we aim to investigate the therapeutic effects of these treatments and exploring the mechanisms. In the present study, NAFLD mouse model was induced by a 10-week HFD. Thereafter, mice adopted continued HFD, ND, or IF for the next 12 weeks. Finally, the liver was then harvested to assess lipid deposition, lipid metabolism, apoptosis, and autophagy, while blood was collected to determine blood glucose and insulin. The results showed that IF and ND treatment improved lipid deposition and metabolic disorder of NAFLD mice; the increasing body weight, liver weight, and HOMA-IR index of HFD mice were also alleviated by IF and ND. Furthermore, IF and ND treatment activated the macrophage migration inhibitory factor (MIF)/AMPK pathway and regulated its downstream autophagy and apoptosis. However, the efficacy of IF was better than ND. Both IF and ND activates MIF signaling and alleviate the lipotoxicity of NAFLD while IF therapy is more effective than ND. The different MIF up-regulation might be the underlying mechanism of why IF benefits more than ND.
Switching to normal diet (ND) is the regular therapy for high-fat diet (HFD)-induced nonalcoholic fatty liver disease (NAFLD). Intermittent fasting (IF) is a unique treatment which may exhibits better therapeutic efficacy. Thus, we aim to investigate the therapeutic effects of these treatments and exploring the mechanisms. In the present study, NAFLD mouse model was induced by a 10-week HFD. Thereafter, mice adopted continued HFD, ND, or IF for the next 12 weeks. Finally, the liver was then harvested to assess lipid deposition, lipid metabolism, apoptosis, and autophagy, while blood was collected to determine blood glucose and insulin. The results showed that IF and ND treatment improved lipid deposition and metabolic disorder of NAFLD mice; the increasing body weight, liver weight, and HOMA-IR index of HFD mice were also alleviated by IF and ND. Furthermore, IF and ND treatment activated the macrophage migration inhibitory factor (MIF)/AMPK pathway and regulated its downstream autophagy and apoptosis. However, the efficacy of IF was better than ND. Both IF and ND activates MIF signaling and alleviate the lipotoxicity of NAFLD while IF therapy is more effective than ND. The different MIF up-regulation might be the underlying mechanism of why IF benefits more than ND.Switching to normal diet (ND) is the regular therapy for high-fat diet (HFD)-induced nonalcoholic fatty liver disease (NAFLD). Intermittent fasting (IF) is a unique treatment which may exhibits better therapeutic efficacy. Thus, we aim to investigate the therapeutic effects of these treatments and exploring the mechanisms. In the present study, NAFLD mouse model was induced by a 10-week HFD. Thereafter, mice adopted continued HFD, ND, or IF for the next 12 weeks. Finally, the liver was then harvested to assess lipid deposition, lipid metabolism, apoptosis, and autophagy, while blood was collected to determine blood glucose and insulin. The results showed that IF and ND treatment improved lipid deposition and metabolic disorder of NAFLD mice; the increasing body weight, liver weight, and HOMA-IR index of HFD mice were also alleviated by IF and ND. Furthermore, IF and ND treatment activated the macrophage migration inhibitory factor (MIF)/AMPK pathway and regulated its downstream autophagy and apoptosis. However, the efficacy of IF was better than ND. Both IF and ND activates MIF signaling and alleviate the lipotoxicity of NAFLD while IF therapy is more effective than ND. The different MIF up-regulation might be the underlying mechanism of why IF benefits more than ND.
Switching to normal diet (ND) is the regular therapy for high-fat diet (HFD)-induced nonalcoholic fatty liver disease (NAFLD). Intermittent fasting (IF) is a unique treatment which may exhibits better therapeutic efficacy. Thus, we aim to investigate the therapeutic effects of these treatments and exploring the mechanisms. In the present study, NAFLD mouse model was induced by a 10-week HFD. Thereafter, mice adopted continued HFD, ND, or IF for the next 12 weeks. Finally, the liver was then harvested to assess lipid deposition, lipid metabolism, apoptosis, and autophagy, while blood was collected to determine blood glucose and insulin. The results showed that IF and ND treatment improved lipid deposition and metabolic disorder of NAFLD mice; the increasing body weight, liver weight, and HOMA-IR index of HFD mice were also alleviated by IF and ND. Furthermore, IF and ND treatment activated the macrophage migration inhibitory factor (MIF)/AMPK pathway and regulated its downstream autophagy and apoptosis. However, the efficacy of IF was better than ND. Both IF and ND activates MIF signaling and alleviate the lipotoxicity of NAFLD while IF therapy is more effective than ND. The different MIF up-regulation might be the underlying mechanism of why IF benefits more than ND.
Abstract Switching to normal diet (ND) is the regular therapy for high-fat diet (HFD)-induced nonalcoholic fatty liver disease (NAFLD). Intermittent fasting (IF) is a unique treatment which may exhibits better therapeutic efficacy. Thus, we aim to investigate the therapeutic effects of these treatments and exploring the mechanisms. In the present study, NAFLD mouse model was induced by a 10-week HFD. Thereafter, mice adopted continued HFD, ND, or IF for the next 12 weeks. Finally, the liver was then harvested to assess lipid deposition, lipid metabolism, apoptosis, and autophagy, while blood was collected to determine blood glucose and insulin. The results showed that IF and ND treatment improved lipid deposition and metabolic disorder of NAFLD mice; the increasing body weight, liver weight, and HOMA-IR index of HFD mice were also alleviated by IF and ND. Furthermore, IF and ND treatment activated the macrophage migration inhibitory factor (MIF)/AMPK pathway and regulated its downstream autophagy and apoptosis. However, the efficacy of IF was better than ND. Both IF and ND activates MIF signaling and alleviate the lipotoxicity of NAFLD while IF therapy is more effective than ND. The different MIF up-regulation might be the underlying mechanism of why IF benefits more than ND.
ArticleNumber 13068
Author Qiu, Ling
Li, Dezhao
Dong, Jie
Qi, Dake
Dun, Yaoshan
Zeng, Tanghao
Liu, Suixin
Zhou, Nanjiang
Zhang, Jie
Ripley-Gonzalez, Jeffrey W.
You, Baiyang
Author_xml – sequence: 1
  givenname: Dezhao
  surname: Li
  fullname: Li, Dezhao
  organization: Division of Cardiac Rehabilitation, Department of Physical Medicine and Rehabilitation, Xiangya Hospital Central South University
– sequence: 2
  givenname: Yaoshan
  surname: Dun
  fullname: Dun, Yaoshan
  organization: Division of Cardiac Rehabilitation, Department of Physical Medicine and Rehabilitation, Xiangya Hospital Central South University, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital Central South University
– sequence: 3
  givenname: Dake
  surname: Qi
  fullname: Qi, Dake
  organization: College of Pharmacy, University of Manitoba
– sequence: 4
  givenname: Jeffrey W.
  surname: Ripley-Gonzalez
  fullname: Ripley-Gonzalez, Jeffrey W.
  organization: Division of Cardiac Rehabilitation, Department of Physical Medicine and Rehabilitation, Xiangya Hospital Central South University
– sequence: 5
  givenname: Jie
  surname: Dong
  fullname: Dong, Jie
  organization: Division of Cardiac Rehabilitation, Department of Physical Medicine and Rehabilitation, Xiangya Hospital Central South University
– sequence: 6
  givenname: Nanjiang
  surname: Zhou
  fullname: Zhou, Nanjiang
  organization: Division of Cardiac Rehabilitation, Department of Physical Medicine and Rehabilitation, Xiangya Hospital Central South University
– sequence: 7
  givenname: Ling
  surname: Qiu
  fullname: Qiu, Ling
  organization: Division of Cardiac Rehabilitation, Department of Physical Medicine and Rehabilitation, Xiangya Hospital Central South University, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital Central South University
– sequence: 8
  givenname: Jie
  surname: Zhang
  fullname: Zhang, Jie
  organization: Division of Cardiac Rehabilitation, Department of Physical Medicine and Rehabilitation, Xiangya Hospital Central South University
– sequence: 9
  givenname: Tanghao
  surname: Zeng
  fullname: Zeng, Tanghao
  organization: Division of Cardiac Rehabilitation, Department of Physical Medicine and Rehabilitation, Xiangya Hospital Central South University
– sequence: 10
  givenname: Baiyang
  surname: You
  fullname: You, Baiyang
  email: youbaiyang@csu.edu.cn
  organization: Division of Cardiac Rehabilitation, Department of Physical Medicine and Rehabilitation, Xiangya Hospital Central South University, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital Central South University
– sequence: 11
  givenname: Suixin
  surname: Liu
  fullname: Liu, Suixin
  email: liusuixin@csu.edu.cn
  organization: Division of Cardiac Rehabilitation, Department of Physical Medicine and Rehabilitation, Xiangya Hospital Central South University, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital Central South University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37567977$$D View this record in MEDLINE/PubMed
BookMark eNp9kstu3CAYha0qVZOmeYEuKkvddOOWq4FVVUW9jBSpm3aNMBebkQ1TYEaaZ8hLl5lJ0ySLsAHBOR8_P-d1cxZisE3zFoKPEGD-KRNIBe8Awh0BmOGOvmguECC0Qxihswfr8-Yq5zWogyJBoHjVnGNGeyYYu2huV6HYtPhSbCitU7n4MLZKF79TxeZ2UTrFzaRG2y5-TKr4GFofJj_4EtO-OnSdWxVMq-bZ7vzRNflx6pwqrfG2dD6YrbamrS9Qs45TnL2uxlL27ex3NlVVtirbN81Lp-Zsr-7my-b3t6-_rn90Nz-_r66_3HSaElg6CJAQPSEDxYY6AgcnEABKc8tpj8ygCR8AMBjrHhrdGy60xr2ijBDnei7wZbM6cU1Ua7lJflFpL6Py8rgR0yhVKl7PVgrLegcdA8TWdioteqY0I5w7ZqAgprI-n1ib7bBYo2sXk5ofQR-fBD_JMe4kBARVAqmED3eEFP9sbS5y8VnbeVbBxm2WiFOAQQ9wX6Xvn0jXcZtqUw8qIiBnVNCqevewpPta_n16FaCToH5tzsm6ewkE8hAueQqXrOGSx3DJA5U_MWlfjnGoz_Lz81Z8suZ6Txht-l_2M66__-rmEg
CitedBy_id crossref_primary_10_1016_j_jnha_2024_100165
crossref_primary_10_1111_imm_13829
crossref_primary_10_3390_metabo15030150
crossref_primary_10_3390_molecules29050976
crossref_primary_10_1186_s12986_024_00885_x
crossref_primary_10_1186_s12944_024_02108_x
Cites_doi 10.3748/wjg.v24.i25.2661
10.1016/j.jnutbio.2020.108403
10.1002/hep.20701
10.1530/REP-19-0259
10.1161/CIRCULATIONAHA.110.953208
10.1056/NEJMra1905136
10.1002/biof.1711
10.1097/SHK.0000000000000976
10.1016/j.cmet.2019.07.016
10.1016/j.nut.2019.03.015
10.1001/jamanetworkopen.2021.39558
10.4168/aair.2021.13.1.88
10.1002/path.4829
10.1159/000366323
10.1038/s41430-021-00909-2
10.1177/21650799211026980
10.1172/JCI39738
10.1111/j.1872-034X.2007.00008.x
10.1016/j.cellsig.2019.01.006
10.1038/nature06504
10.3390/ijms22052350
10.1530/JOE-13-0135
10.1038/s41598-020-67806-9
10.3390/nu14010091
10.1016/j.cmet.2022.12.001
10.1186/s12944-018-0852-z
10.1038/35041591
10.3389/fendo.2022.961231
10.1530/JOE-19-0393
10.1016/j.redox.2020.101635
10.1007/BF00280883
10.1016/j.lfs.2021.119314
10.1016/j.jhep.2019.01.026
10.1111/j.1582-4934.2010.01041.x
10.1073/pnas.1107023108
ContentType Journal Article
Copyright The Author(s) 2023
2023. Springer Nature Limited.
Springer Nature Limited 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Springer Nature Limited 2023
Copyright_xml – notice: The Author(s) 2023
– notice: 2023. Springer Nature Limited.
– notice: Springer Nature Limited 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: Springer Nature Limited 2023
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88A
88E
88I
8FE
8FH
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M2P
M7P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOA
DOI 10.1038/s41598-023-40373-5
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Journals
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
Science Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database
MEDLINE - Academic
MEDLINE

CrossRef


Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 5
  dbid: BENPR
  name: ProQuest Central Database Suite (ProQuest)
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2045-2322
EndPage 9
ExternalDocumentID oai_doaj_org_article_9e76f1f704e045ac967ac7488f7d194d
PMC10421944
37567977
10_1038_s41598_023_40373_5
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: National Natural Science Foundation of China
  grantid: 82002403; 82102672; 82172549
– fundername: Natural Science Foundation of Hunan Province
  grantid: 2022JJ40842; 2021JJ70073
– fundername: ;
  grantid: 2022JJ40842; 2021JJ70073
– fundername: ;
  grantid: 82002403; 82102672; 82172549
GroupedDBID 0R~
3V.
4.4
53G
5VS
7X7
88A
88E
88I
8FE
8FH
8FI
8FJ
AAFWJ
AAJSJ
AAKDD
ABDBF
ABUWG
ACGFS
ACSMW
ACUHS
ADBBV
ADRAZ
AENEX
AEUYN
AFKRA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
C6C
CCPQU
DIK
DWQXO
EBD
EBLON
EBS
ESX
FYUFA
GNUQQ
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
KQ8
LK8
M0L
M1P
M2P
M48
M7P
M~E
NAO
OK1
PIMPY
PQQKQ
PROAC
PSQYO
RNT
RNTTT
RPM
SNYQT
UKHRP
AASML
AAYXX
AFPKN
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
7XB
8FK
AARCD
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
Q9U
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c541t-10299644b53d5f41bf9200ac8e8562dbc48b00d33c61dc6d89cc36a5744ff6893
IEDL.DBID M48
ISSN 2045-2322
IngestDate Wed Aug 27 01:25:23 EDT 2025
Thu Aug 21 18:40:50 EDT 2025
Thu Aug 07 15:10:10 EDT 2025
Wed Aug 13 04:10:18 EDT 2025
Thu Apr 03 07:09:22 EDT 2025
Thu Apr 24 23:08:40 EDT 2025
Tue Jul 01 03:57:14 EDT 2025
Fri Feb 21 02:37:12 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License 2023. Springer Nature Limited.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c541t-10299644b53d5f41bf9200ac8e8562dbc48b00d33c61dc6d89cc36a5744ff6893
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1038/s41598-023-40373-5
PMID 37567977
PQID 2849187595
PQPubID 2041939
PageCount 9
ParticipantIDs doaj_primary_oai_doaj_org_article_9e76f1f704e045ac967ac7488f7d194d
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10421944
proquest_miscellaneous_2850306036
proquest_journals_2849187595
pubmed_primary_37567977
crossref_primary_10_1038_s41598_023_40373_5
crossref_citationtrail_10_1038_s41598_023_40373_5
springer_journals_10_1038_s41598_023_40373_5
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-08-11
PublicationDateYYYYMMDD 2023-08-11
PublicationDate_xml – month: 08
  year: 2023
  text: 2023-08-11
  day: 11
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Scientific reports
PublicationTitleAbbrev Sci Rep
PublicationTitleAlternate Sci Rep
PublicationYear 2023
Publisher Nature Publishing Group UK
Nature Publishing Group
Nature Portfolio
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
– name: Nature Portfolio
References Crisostomo (CR3) 2019; 158
Rozanski (CR5) 2021
Matthews (CR36) 1985; 28
Cui (CR13) 2022; 13
Johari (CR25) 2020; 10
You (CR35) 2020; 244
Simons (CR32) 2011; 15
Li (CR15) 2021; 13
Różański (CR23) 2021
Gao, Tsintzas, Macdonald, Cordon, Taylor (CR7) 2022; 76
Moon, Song, Choi, Ryu, Suh (CR17) 2013; 218
Ito (CR18) 2007; 37
Li (CR33) 2021; 273
Littlejohns, Lin, Angelini, Halestrap, Suleiman (CR4) 2014; 34
Kleemann (CR30) 2000; 408
Kleiner (CR34) 2005; 41
Kanda (CR8) 2018; 24
Patikorn (CR2) 2021; 4
Chao, Chen, Chuang, Yeh (CR14) 2018; 50
Ok, Ko, Bae (CR22) 2018; 17
Zhang (CR27) 2020; 83
Jankauskas, Wong, Bucala, Djudjaj, Boor (CR9) 2019; 57
Ezpeleta (CR26) 2023; 35
Qi (CR12) 2009; 119
Phillips (CR21) 2021; 69
Stekovic (CR24) 2019; 30
Mantovani, Dalbeni (CR1) 2021
Liu, Page, Hutchison, Wittert, Heilbronn (CR28) 2019; 66
Lau, Zhang, Yu (CR19) 2017; 241
Heinrichs (CR10) 2011; 108
Ma (CR29) 2010; 122
Gao (CR16) 2020; 36
Gligorovska (CR11) 2021; 47
Allaire, Rautou, Codogno, Lotersztajn (CR20) 2019; 70
Miller (CR31) 2008; 451
de Cabo, Mattson (CR6) 2019; 381
M Ezpeleta (40373_CR26) 2023; 35
H Ma (40373_CR29) 2010; 122
L Crisostomo (40373_CR3) 2019; 158
EJ Miller (40373_CR31) 2008; 451
N Cui (40373_CR13) 2022; 13
H Zhang (40373_CR27) 2020; 83
B Liu (40373_CR28) 2019; 66
L Gligorovska (40373_CR11) 2021; 47
A Mantovani (40373_CR1) 2021
DP Ok (40373_CR22) 2018; 17
D Heinrichs (40373_CR10) 2011; 108
R Li (40373_CR15) 2021; 13
M Ito (40373_CR18) 2007; 37
M Allaire (40373_CR20) 2019; 70
HY Moon (40373_CR17) 2013; 218
JA Phillips (40373_CR21) 2021; 69
DR Matthews (40373_CR36) 1985; 28
CH Chao (40373_CR14) 2018; 50
S Stekovic (40373_CR24) 2019; 30
B You (40373_CR35) 2020; 244
T Kanda (40373_CR8) 2018; 24
DE Kleiner (40373_CR34) 2005; 41
G Różański (40373_CR23) 2021
R Kleemann (40373_CR30) 2000; 408
D Simons (40373_CR32) 2011; 15
Y Gao (40373_CR7) 2022; 76
Y Gao (40373_CR16) 2020; 36
H Li (40373_CR33) 2021; 273
R de Cabo (40373_CR6) 2019; 381
MI Johari (40373_CR25) 2020; 10
SS Jankauskas (40373_CR9) 2019; 57
B Littlejohns (40373_CR4) 2014; 34
G Rozanski (40373_CR5) 2021
D Qi (40373_CR12) 2009; 119
C Patikorn (40373_CR2) 2021; 4
JK Lau (40373_CR19) 2017; 241
References_xml – volume: 24
  start-page: 2661
  year: 2018
  end-page: 2672
  ident: CR8
  article-title: Apoptosis and non-alcoholic fatty liver diseases
  publication-title: World J. Gastroenterol.
  doi: 10.3748/wjg.v24.i25.2661
– volume: 83
  start-page: 108403
  year: 2020
  ident: CR27
  article-title: Alternate-day fasting alleviates diabetes-induced glycolipid metabolism disorders: Roles of FGF21 and bile acids
  publication-title: J. Nutr. Biochem.
  doi: 10.1016/j.jnutbio.2020.108403
– volume: 41
  start-page: 1313
  year: 2005
  end-page: 1321
  ident: CR34
  article-title: Design and validation of a histological scoring system for nonalcoholic fatty liver disease
  publication-title: Hepatology
  doi: 10.1002/hep.20701
– volume: 158
  start-page: 377
  year: 2019
  end-page: 387
  ident: CR3
  article-title: A switch from high-fat to normal diet does not restore sperm quality but prevents metabolic syndrome
  publication-title: Reproduction
  doi: 10.1530/REP-19-0259
– volume: 122
  start-page: 282
  year: 2010
  end-page: 292
  ident: CR29
  article-title: Impaired macrophage migration inhibitory factor-AMP-activated protein kinase activation and ischemic recovery in the senescent heart
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.110.953208
– volume: 381
  start-page: 2541
  year: 2019
  end-page: 2551
  ident: CR6
  article-title: Effects of intermittent fasting on health, aging, and disease
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMra1905136
– volume: 47
  start-page: 363
  year: 2021
  end-page: 375
  ident: CR11
  article-title: Macrophage migration inhibitory factor deficiency aggravates effects of fructose-enriched diet on lipid metabolism in the mouse liver
  publication-title: BioFactors
  doi: 10.1002/biof.1711
– volume: 50
  start-page: 103
  year: 2018
  end-page: 111
  ident: CR14
  article-title: Macrophage migration inhibitory factor-induced autophagy contributes to thrombin-triggered endothelial hyperpermeability in sepsis
  publication-title: Shock
  doi: 10.1097/SHK.0000000000000976
– volume: 30
  start-page: 462
  year: 2019
  end-page: 76 e6
  ident: CR24
  article-title: Alternate day fasting improves physiological and molecular markers of aging in healthy, Non-obese humans
  publication-title: Cell Metab.
  doi: 10.1016/j.cmet.2019.07.016
– volume: 66
  start-page: 38
  year: 2019
  end-page: 43
  ident: CR28
  article-title: Intermittent fasting increases energy expenditure and promotes adipose tissue browning in mice
  publication-title: Nutrition
  doi: 10.1016/j.nut.2019.03.015
– volume: 4
  year: 2021
  ident: CR2
  article-title: Intermittent fasting and obesity-related health outcomes: An umbrella review of meta-analyses of randomized clinical trials
  publication-title: JAMA Netw. Open.
  doi: 10.1001/jamanetworkopen.2021.39558
– volume: 13
  start-page: 88
  year: 2021
  end-page: 105
  ident: CR15
  article-title: The Role of macrophage migration inhibitory factor (MIF) in asthmatic airway remodeling
  publication-title: Allergy Asthma Immunol. Res.
  doi: 10.4168/aair.2021.13.1.88
– volume: 241
  start-page: 36
  year: 2017
  end-page: 44
  ident: CR19
  article-title: Animal models of non-alcoholic fatty liver disease: Current perspectives and recent advances
  publication-title: J. Pathol.
  doi: 10.1002/path.4829
– volume: 34
  start-page: 1090
  year: 2014
  end-page: 1100
  ident: CR4
  article-title: Switching back to normal diet following high-fat diet feeding reduces cardiac vulnerability to ischaemia and reperfusion injury
  publication-title: Cell Physiol. Biochem.
  doi: 10.1159/000366323
– volume: 76
  start-page: 65
  year: 2022
  end-page: 73
  ident: CR7
  article-title: Effects of intermittent (5:2) or continuous energy restriction on basal and postprandial metabolism: A randomised study in normal-weight, young participants
  publication-title: Eur. J. Clin. Nutr.
  doi: 10.1038/s41430-021-00909-2
– volume: 69
  start-page: 395
  year: 2021
  ident: CR21
  article-title: Dietary guidelines for Americans, 2020–2025
  publication-title: Workplace Health Saf.
  doi: 10.1177/21650799211026980
– volume: 119
  start-page: 3807
  year: 2009
  end-page: 3816
  ident: CR12
  article-title: Cardiac macrophage migration inhibitory factor inhibits JNK pathway activation and injury during ischemia/reperfusion
  publication-title: J. Clin. Investig.
  doi: 10.1172/JCI39738
– volume: 37
  start-page: 50
  year: 2007
  end-page: 57
  ident: CR18
  article-title: Longitudinal analysis of murine steatohepatitis model induced by chronic exposure to high-fat diet
  publication-title: Hepatol. Res.
  doi: 10.1111/j.1872-034X.2007.00008.x
– volume: 57
  start-page: 76
  year: 2019
  end-page: 88
  ident: CR9
  article-title: Evolving complexity of MIF signaling
  publication-title: Cell Signal.
  doi: 10.1016/j.cellsig.2019.01.006
– volume: 451
  start-page: 578
  year: 2008
  end-page: 582
  ident: CR31
  article-title: Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart
  publication-title: Nature
  doi: 10.1038/nature06504
– year: 2021
  ident: CR1
  article-title: Treatments for NAFLD: State of Art
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms22052350
– volume: 218
  start-page: 339
  year: 2013
  end-page: 348
  ident: CR17
  article-title: Involvement of exercise-induced macrophage migration inhibitory factor in the prevention of fatty liver disease
  publication-title: J. Endocrinol.
  doi: 10.1530/JOE-13-0135
– volume: 10
  start-page: 10599
  year: 2020
  ident: CR25
  article-title: Author Correction: A randomised controlled trial on the effectiveness and adherence of modified alternate-day calorie restriction in improving activity of non-alcoholic fatty liver disease
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-020-67806-9
– year: 2021
  ident: CR5
  article-title: Effect of different types of intermittent fasting on biochemical and anthropometric parameters among patients with metabolic-associated fatty liver disease (MAFLD)—A systematic review
  publication-title: Nutrients
  doi: 10.3390/nu14010091
– volume: 35
  start-page: 56
  year: 2023
  end-page: 70.e3
  ident: CR26
  article-title: Effect of alternate day fasting combined with aerobic exercise on non-alcoholic fatty liver disease: A randomized controlled trial
  publication-title: Cell Metab.
  doi: 10.1016/j.cmet.2022.12.001
– volume: 17
  start-page: 207
  year: 2018
  ident: CR22
  article-title: Exercise without dietary changes alleviates nonalcoholic fatty liver disease without weight loss benefits
  publication-title: Lipids Health Dis.
  doi: 10.1186/s12944-018-0852-z
– volume: 408
  start-page: 211
  year: 2000
  end-page: 216
  ident: CR30
  article-title: Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1
  publication-title: Nature
  doi: 10.1038/35041591
– volume: 13
  start-page: 961231
  year: 2022
  ident: CR13
  article-title: Exercise inhibits JNK pathway activation and lipotoxicity via macrophage migration inhibitory factor in nonalcoholic fatty liver disease
  publication-title: Front. Endocrinol. (Lausanne).
  doi: 10.3389/fendo.2022.961231
– volume: 244
  start-page: 383
  year: 2020
  end-page: 393
  ident: CR35
  article-title: Anti-insulin resistance effects of salidroside through mitochondrial quality control
  publication-title: J. Endocrinol.
  doi: 10.1530/JOE-19-0393
– volume: 36
  start-page: 101635
  year: 2020
  ident: CR16
  article-title: Exercise and dietary intervention ameliorate high-fat diet-induced NAFLD and liver aging by inducing lipophagy
  publication-title: Redox Biol.
  doi: 10.1016/j.redox.2020.101635
– year: 2021
  ident: CR23
  article-title: Effect of different types of intermittent fasting on biochemical and anthropometric parameters among patients with metabolic-associated fatty liver disease (MAFLD)—A systematic review
  publication-title: Nutrients
  doi: 10.3390/nu14010091
– volume: 28
  start-page: 412
  year: 1985
  end-page: 419
  ident: CR36
  article-title: Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
  publication-title: Diabetologia
  doi: 10.1007/BF00280883
– volume: 273
  year: 2021
  ident: CR33
  article-title: Exercise improves lipid droplet metabolism disorder through activation of AMPK-mediated lipophagy in NAFLD
  publication-title: Life Sci.
  doi: 10.1016/j.lfs.2021.119314
– volume: 70
  start-page: 985
  year: 2019
  end-page: 998
  ident: CR20
  article-title: Autophagy in liver diseases: Time for translation?
  publication-title: J. Hepatol.
  doi: 10.1016/j.jhep.2019.01.026
– volume: 15
  start-page: 668
  year: 2011
  end-page: 678
  ident: CR32
  article-title: Hypoxia-induced endothelial secretion of macrophage migration inhibitory factor and role in endothelial progenitor cell recruitment
  publication-title: J. Cell Mol. Med.
  doi: 10.1111/j.1582-4934.2010.01041.x
– volume: 108
  start-page: 17444
  year: 2011
  end-page: 17449
  ident: CR10
  article-title: Macrophage migration inhibitory factor (MIF) exerts antifibrotic effects in experimental liver fibrosis via CD74
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.1107023108
– volume: 408
  start-page: 211
  year: 2000
  ident: 40373_CR30
  publication-title: Nature
  doi: 10.1038/35041591
– volume: 17
  start-page: 207
  year: 2018
  ident: 40373_CR22
  publication-title: Lipids Health Dis.
  doi: 10.1186/s12944-018-0852-z
– volume: 28
  start-page: 412
  year: 1985
  ident: 40373_CR36
  publication-title: Diabetologia
  doi: 10.1007/BF00280883
– volume: 13
  start-page: 88
  year: 2021
  ident: 40373_CR15
  publication-title: Allergy Asthma Immunol. Res.
  doi: 10.4168/aair.2021.13.1.88
– year: 2021
  ident: 40373_CR5
  publication-title: Nutrients
  doi: 10.3390/nu14010091
– volume: 66
  start-page: 38
  year: 2019
  ident: 40373_CR28
  publication-title: Nutrition
  doi: 10.1016/j.nut.2019.03.015
– volume: 10
  start-page: 10599
  year: 2020
  ident: 40373_CR25
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-020-67806-9
– volume: 122
  start-page: 282
  year: 2010
  ident: 40373_CR29
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.110.953208
– volume: 218
  start-page: 339
  year: 2013
  ident: 40373_CR17
  publication-title: J. Endocrinol.
  doi: 10.1530/JOE-13-0135
– volume: 30
  start-page: 462
  year: 2019
  ident: 40373_CR24
  publication-title: Cell Metab.
  doi: 10.1016/j.cmet.2019.07.016
– volume: 36
  start-page: 101635
  year: 2020
  ident: 40373_CR16
  publication-title: Redox Biol.
  doi: 10.1016/j.redox.2020.101635
– volume: 34
  start-page: 1090
  year: 2014
  ident: 40373_CR4
  publication-title: Cell Physiol. Biochem.
  doi: 10.1159/000366323
– volume: 50
  start-page: 103
  year: 2018
  ident: 40373_CR14
  publication-title: Shock
  doi: 10.1097/SHK.0000000000000976
– volume: 47
  start-page: 363
  year: 2021
  ident: 40373_CR11
  publication-title: BioFactors
  doi: 10.1002/biof.1711
– year: 2021
  ident: 40373_CR1
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms22052350
– volume: 35
  start-page: 56
  year: 2023
  ident: 40373_CR26
  publication-title: Cell Metab.
  doi: 10.1016/j.cmet.2022.12.001
– volume: 24
  start-page: 2661
  year: 2018
  ident: 40373_CR8
  publication-title: World J. Gastroenterol.
  doi: 10.3748/wjg.v24.i25.2661
– volume: 241
  start-page: 36
  year: 2017
  ident: 40373_CR19
  publication-title: J. Pathol.
  doi: 10.1002/path.4829
– volume: 13
  start-page: 961231
  year: 2022
  ident: 40373_CR13
  publication-title: Front. Endocrinol. (Lausanne).
  doi: 10.3389/fendo.2022.961231
– volume: 273
  year: 2021
  ident: 40373_CR33
  publication-title: Life Sci.
  doi: 10.1016/j.lfs.2021.119314
– volume: 69
  start-page: 395
  year: 2021
  ident: 40373_CR21
  publication-title: Workplace Health Saf.
  doi: 10.1177/21650799211026980
– volume: 57
  start-page: 76
  year: 2019
  ident: 40373_CR9
  publication-title: Cell Signal.
  doi: 10.1016/j.cellsig.2019.01.006
– volume: 83
  start-page: 108403
  year: 2020
  ident: 40373_CR27
  publication-title: J. Nutr. Biochem.
  doi: 10.1016/j.jnutbio.2020.108403
– volume: 244
  start-page: 383
  year: 2020
  ident: 40373_CR35
  publication-title: J. Endocrinol.
  doi: 10.1530/JOE-19-0393
– volume: 70
  start-page: 985
  year: 2019
  ident: 40373_CR20
  publication-title: J. Hepatol.
  doi: 10.1016/j.jhep.2019.01.026
– volume: 37
  start-page: 50
  year: 2007
  ident: 40373_CR18
  publication-title: Hepatol. Res.
  doi: 10.1111/j.1872-034X.2007.00008.x
– year: 2021
  ident: 40373_CR23
  publication-title: Nutrients
  doi: 10.3390/nu14010091
– volume: 451
  start-page: 578
  year: 2008
  ident: 40373_CR31
  publication-title: Nature
  doi: 10.1038/nature06504
– volume: 15
  start-page: 668
  year: 2011
  ident: 40373_CR32
  publication-title: J. Cell Mol. Med.
  doi: 10.1111/j.1582-4934.2010.01041.x
– volume: 381
  start-page: 2541
  year: 2019
  ident: 40373_CR6
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMra1905136
– volume: 76
  start-page: 65
  year: 2022
  ident: 40373_CR7
  publication-title: Eur. J. Clin. Nutr.
  doi: 10.1038/s41430-021-00909-2
– volume: 158
  start-page: 377
  year: 2019
  ident: 40373_CR3
  publication-title: Reproduction
  doi: 10.1530/REP-19-0259
– volume: 119
  start-page: 3807
  year: 2009
  ident: 40373_CR12
  publication-title: J. Clin. Investig.
  doi: 10.1172/JCI39738
– volume: 4
  year: 2021
  ident: 40373_CR2
  publication-title: JAMA Netw. Open.
  doi: 10.1001/jamanetworkopen.2021.39558
– volume: 108
  start-page: 17444
  year: 2011
  ident: 40373_CR10
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.1107023108
– volume: 41
  start-page: 1313
  year: 2005
  ident: 40373_CR34
  publication-title: Hepatology
  doi: 10.1002/hep.20701
SSID ssj0000529419
Score 2.4391856
Snippet Switching to normal diet (ND) is the regular therapy for high-fat diet (HFD)-induced nonalcoholic fatty liver disease (NAFLD). Intermittent fasting (IF) is a...
Abstract Switching to normal diet (ND) is the regular therapy for high-fat diet (HFD)-induced nonalcoholic fatty liver disease (NAFLD). Intermittent fasting...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 13068
SubjectTerms 631/443/319/1488/393
692/163/2743/393
Animals
Apoptosis
Autophagy
Blood
Body weight
Diet
Diet, High-Fat - adverse effects
Fasting
Fatty liver
High fat diet
Humanities and Social Sciences
Intermittent Fasting
Leukocyte migration
Lipid Metabolism
Lipids
Liver
Liver - metabolism
Liver diseases
Macrophage migration inhibitory factor
Macrophage Migration-Inhibitory Factors - metabolism
Metabolic disorders
Mice
Mice, Inbred C57BL
multidisciplinary
Non-alcoholic Fatty Liver Disease - etiology
Non-alcoholic Fatty Liver Disease - metabolism
Non-alcoholic Fatty Liver Disease - therapy
Science
Science (multidisciplinary)
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQJSQuCCiPlIKMxA2irtfvY0FUVSU4Uak3y_GDjdQNiE0r9Tf0T3fGzi5dnheusa1M5uH5JmPPEPJaBc5DlBqCnC5DgCJTa9SMt8ZkP7ddBLng5eSPn9TxqTg5k2e3Wn3hmbBaHrgy7sAmrTLLeiYSoA8frNI-aFC7rCME4BF3X_B5t4KpWtV7bgWz0y2ZGTcHK_BUeJtszoEirnkrtzxRKdj_O5T562HJnzKmxREdPSD3JwRJDyvlD8mdNDwid2tPyatdcl3-8S37EcDwSLNf4blmitcXLhFW0qXHpl0L2Ebosv9S5U_7YdF3PebbaW3AQ_0QKbZZuezLKqxq3GY_0tinsYU4HjQi0gFhfGmx2wdYOI5X9BzPedAp7fOYnB59-Pz-uJ06LrRBCjbCngzeCRBSJ3mUWbAuW7AiH0wygJNiF4QBM40gXsViUNHYELjyUguRswLo84TswKvTM0ItRCoyshRYiEJ41kXAVlyFAJDSZi0awtbcd2EqR45dMc5dSYtz46rEHEjMFYk52ZA3mzXfajGOv85-h0LdzMRC2uUBqJeb1Mv9S70asr9WCTdZ98qBS7cMAj0L73i1GQa7xGSLH9LXC5wjMRyDT27I06pBG0q4lkoD8G6I2dKtLVK3R4Z-UWp_Q_QMPkYA-96u1fAHXX_mxd7_4MVzcm-O9oMFgdk-2Rm_X6QXAMnG7mWxvhun1DNq
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagCIkL4k2gICNxg6jr9Ss-IUBUFRKcqLQ3y_GjG6mbLd20Un8Df5oZx5tqefSa2IrjeX3jGc8Q8lZ5zn2QGpycNoGDImPdqBmvmya5uWkD0AUvJ3_7ro6OxdeFXJQDt01Jq9zqxKyow9rjGfkBqFHDAFwb-eHsZ41dozC6Wlpo3CZ3sHQZpnTphZ7OWDCKJZgpd2VmvDnYgL3CO2VzDuvimtdyxx7lsv3_wpp_p0z-ETfN5ujwAblfcCT9OBL-IbkV-0fk7thZ8uox-ZVP-lbdAJB4oMltMLuZ4iWGSwSXdOWwddcSlAlddScjF9CuX3Zth1F3Orbhoa4PFJutXHZ5FtY2rpMbaOjiUIM3D3wRaI9gPjfa7TxMHIYreorZHrQEf56Q48MvPz4f1aXvQu2lYANoZrBRgJNayYNMgrXJgCw538QG0FJovWhAWAMQWbHgVWiM91w5qYVISQEAekr24NPxOaEG_BUZWPTMByEcawMgLK68B2BpkhYVYdvdt74UJcfeGKc2B8d5Y0eKWaCYzRSzsiLvpjlnY0mOG0d_QqJOI7Gcdn6wPj-xRTqtiVollvRMRIC4zhulndeg25IOzIhQkf0tS9gi4xt7zZEVeTO9BunEkIvr4_oCx0h0yuCXK_Js5KBpJVxLpQF-V6TZ4a2dpe6-6btlrgAOPjRYGgHb937Lhtfr-v9evLj5N16Se3OUDCz4y_bJ3nB-EV8B5Bra11mufgPm8isf
  priority: 102
  providerName: ProQuest
– databaseName: Springer Nature OA Free Journals
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELZKERIXxJtAQUbiBhHr9fsIK6oKCU5U6s1y_OhG6qaom1bqb-BPM-M80EJB4prYieOZ8XyTeRHyRgXOQ5QajJwmg4EiU23UgtfGZL-0TQS6YHLyl6_q6Fh8PpEne2Q55cKUoP1S0rIc01N02PstKBpMBltyeCDXvJa3yG0s3Y5cvVKr-b8Keq4Es2N-zIKbG6bu6KBSqv8mfPlnmORvvtKigg7vk3sjdqQfhtU-IHupe0juDN0krx-RH-Xv3qbtAQb3NPstRjRTTFy4QkBJNx7bda3hAKGb9nSgPG27ddu06GmnQ-sd6rtIscHKVVtmYT3jOvuexjb1NVjwwAuRdgjgS3PdNsDEvr-mZxjhQUeHz2NyfPjp2-qoHnst1EEK1sNpDHoJsFEjeZRZsCZbkB8fTDKAkGIThAEBjUBYxWJQ0dgQuPISKJCzAtDzhOzDq9MzQi3YKDKyFFiIQnjWREBVXIUAYNJmLSrCpt13YSxEjv0wzlxxiHPjBoo5oJgrFHOyIm_nOd-HMhz_HP0RiTqPxBLa5cL5xakbWcrZpFVmWS9EAljrg1XaBw3nWdaRWRErcjCxhBvleutAmVsGJp6Fd7yeb4NEopvFd-n8EsdINMTgkyvydOCgeSVcS6UBclfE7PDWzlJ373TtulT9BrsZtIuA7Xs3seGvdf19L57_3_AX5O4SJQWL_rIDst9fXKaXALv65lWRs5_rDCjL
  priority: 102
  providerName: Springer Nature
Title Intermittent fasting activates macrophage migration inhibitory factor and alleviates high-fat diet-induced nonalcoholic fatty liver disease
URI https://link.springer.com/article/10.1038/s41598-023-40373-5
https://www.ncbi.nlm.nih.gov/pubmed/37567977
https://www.proquest.com/docview/2849187595
https://www.proquest.com/docview/2850306036
https://pubmed.ncbi.nlm.nih.gov/PMC10421944
https://doaj.org/article/9e76f1f704e045ac967ac7488f7d194d
Volume 13
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwELf2ISReEN_rGJWReIPAXH_FDwh11aap0iYEVOpb5NjxGqnNWJtN9G_gn-bOSYsKBYmnSIkdO7473-9yvjtCXivHufNSg5GTBzBQZJGk6pgnaRpsz-Qe6ILByReX6nwkhmM53iGrckftAi62mnZYT2o0n777frP8CAL_oQkZT98vQAlhoFiPw2Bc80Tukn3QTBoF9aKF-02u754RsdYHJmFPAEz02jia7a_Z0FUxpf82HPrnccrffKpRVZ09JA9ajEn7DVM8IjtF9Zjca6pOLp-QH_Ev4KysAS7XNNgFnnymGOBwh8CTziyW9ZrARkNn5VXDIbSsJmVeokeeNiV6qK08xUIsd2XshXmPk2Br6suiTsDSB57xtEKgH4vwlg461vWSTvEkCG0dQ0_J6Oz06-A8aWsyJE4KVsOuDfoLMFQuuZdBsDwYkDPr0iIFJOVzJ1IQZA8MoJh3yqfGOa6s1EKEoAAcPSN7MHRxQKgBW0Z6VjjmvBCW5R7QF1fOAeg0QYsOYavVz1ybsBzrZkyz6DjnadZQLAOKZZFimeyQN-s-35p0Hf9sfYJEXbfEVNvxxvX8KmslNzOFVoEFfSwKYBrrjNLWadj3gvbMCN8hRyuWyFbsm4HSNwxMQQNjvFo_BslFd4ytiutbbCPRYINP7pDnDQetZ8K1VBqgeYekG7y1MdXNJ1U5idnBwb4GLSRg-d6u2PDXvP6-Fof_tXIvyP0eCgrmBmZHZK-e3xYvAZ3VeZfs6rHukv1-f_hlCNeT08tPn-HuQA268Y9HNwrlT3GoOao
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LbxMxELaqVAguqLyXFjASnGDVOH6tDwhRaJXSNkKolXpbvPa6WanZlGZblN_Af-E3MrOPVOHRW69ZW7E948_feDwzhLxSjnPnpQYjJwtgoMg8TlSfx0kS7MBkHuSCwckHIzU8Ep-P5fEK-dXFwuCzyg4Ta6D2U4d35JsAo4YBuTby_dn3GKtGoXe1K6HRqMVePv8BJtvs3e4nkO_rwWBn-_DjMG6rCsROClYB7gACAwvIJPcyCJYFA5piXZInwAV85kQCquhhCop5p3xinOPKSi1ECCrB5EsA-auCgynTI6tb26MvXxe3Oug3E8y00Tl9nmzO4ITEKLYBh5Xgmsdy6QSsCwX8i93-_UjzD09tfQDurJG7LXOlHxpVu0dW8vI-udXUspw_ID_ru8VJUQEJr2iwM3xPTTFs4hLpLJ1YLBY2Bviik-Kk0TtalOMiK9DPT5vCP9SWnmJ5l8ui7oXZlONgK-qLvIqL0oMmelqi-VCX9i0cdKyqOT3F9yW0dTc9JEc3IpNHpAd_nT8h1ICFJD3LHXNeCMsyD5yOK-eAypqgRURYt_qpa9OgYzWO07R2x_MkbSSWgsTSWmKpjMibRZ-zJgnIta23UKiLlpjAu_5hen6StniQmlyrwILuixxItXVGaes0oGnQnhnhI7LRqUTaososvdoDEXm5-Ax4gE4eW-bTC2wj0QyEKUfkcaNBi5FwLZUGwh-RZEm3loa6_KUsxnXOcbDa4WwTsHxvOzW8Gtf_1-Lp9dN4QW4PDw_20_3d0d46uTPAXYLphtkG6VXnF_kzIHxV9rzdZZR8u-mN_RtsuWhy
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbhMxELaqIhAXxD8LBYwEJ1glju21fUAIKFFLoeJApdwWr71uVmo2pdkW5Rl4I56OGe9uqvDTW69ZW7E9M5-_8dgzhDzPHOfOSwVOThHAQZFlqrMhT7UOdmQKD3LBx8mf97OdA_FxIicb5Ff_FgavVfaYGIHazx2ekQ8ARg0Dcm3kIHTXIr5sj98cf0-xghRGWvtyGq2K7JXLH-C-LV7vboOsX4xG4w9f3--kXYWB1EnBGsAgQGNgBIXkXgbBimBAa6zTpQZe4AsnNKilh-lkzLvMa-Mcz6xUQoSQaUzEBPB_RXHJ0MbURK3OdzCCJpjp3ukMuR4sYK_E92wjDmvCFU_l2l4YSwb8i-f-fV3zj5ht3ArHN8mNjsPSt63S3SIbZX2bXG2rWi7vkJ_xlHFWNUDHGxrsAm9WU3xAcYbEls4slg2bApDRWXXYaiCt6mlVVBjxp20JIGprT7HQy1kVe2Fe5TTYhvqqbNKq9qCTntboSMQiv5WDjk2zpEd404R2gae75OBSJHKPbMJflw8INeArSc9Kx5wXwrLCA7vjmXNAak1QIiGsX_3cdQnRsS7HUR4D81znrcRykFgeJZbLhLxc9Tlu04Fc2PodCnXVElN5xx_mJ4d5hwy5KVUWWFBDUQK9ts5kyjoFuBqUZ0b4hGz1KpF3-LLIz60hIc9WnwEZMNxj63J-im0kOoQw5YTcbzVoNRKuZKaA-idEr-nW2lDXv9TVNGYfB_8ddjkBy_eqV8Pzcf1_LR5ePI2n5BqYc_5pd3_vEbk-QiPBvMNsi2w2J6flY2B-TfEkmhgl3y7bpn8DJalrQg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Intermittent+fasting+activates+macrophage+migration+inhibitory+factor+and+alleviates+high-fat+diet-induced+nonalcoholic+fatty+liver+disease&rft.jtitle=Scientific+reports&rft.au=Li%2C+Dezhao&rft.au=Dun%2C+Yaoshan&rft.au=Qi%2C+Dake&rft.au=Ripley-Gonzalez%2C+Jeffrey+W.&rft.date=2023-08-11&rft.issn=2045-2322&rft.eissn=2045-2322&rft.volume=13&rft.issue=1&rft_id=info:doi/10.1038%2Fs41598-023-40373-5&rft.externalDBID=n%2Fa&rft.externalDocID=10_1038_s41598_023_40373_5
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon